3D MicroPrint GmbH is specialized in the production of micro metal parts by Micro Laser Sintering and the sale of the associated machines. Our company was founded in 2013 in Chemnitz (Germany) as a result of a cooperation between EOS GmbH and 3D-Micromac AG. Experts from both companies have been working with an exceptional pioneering spirit on the development of the Micro Laser Sintering process since 2006. Your requirements for micro metal parts are our inspiration. Thanks to our additive production technology, quality and costs can be optimized while simultaneously expanding the functionality of the specific products of our customers. Only with our MLS technology for metal printing you will reach unmatched detail resolution, fine features at micron size and smooth surfaces while adding complex mechanical working funktions withhin a single printed geometry. We provide for a huge variety of metals printing services from prototyping up to large scale serial production, design and engineering support to development parts, as well our Micro Laser Sintering System DMP 7x. | Small in size, but big in detail! 3D MicroPrint GmbH manufactures high-precision micro metal components using Micro Laser Sintering technology. We offer a comprehensive service from product design and prototype development through to series production.
20/20 Onsite
20/20 Onsite is a specialty vendor for sponsors and CROs conducting clinical trials with ocular endpoints, providing end-to-end ophthalmic trial consultation, clinical field execution, and ongoing support. Through a single-call accountability model, 20/20 Onsite helps sponsors de-risk ocular endpoint complexity and increase the likelihood of on-time, on-budget, protocol-adherent trial success. Its proprietary point-of-need service delivery model reaches participants where they live, work, or congregate, reducing patient burden, improving retention, and supporting diverse enrollment strategies. Backed by proven expertise, nationwide experience at scale, and validated regulatory rigor, 20/20 Onsite has supported more than 45 clinical trials, served over 100,000 patients, and consistently delivered Net Promoter Scores above 95. To learn more about how 20/20 Onsite delivers single-call ophthalmic execution for trials with ocular endpoints, visit www.2020onsite.com.
10ZiG Technology
10ZiG delivers secure, standardized, and centrally managed endpoints for healthcare organizations. Our Imprivata Ready thin clients, zero clients, and PC repurposing software enable safe access to clinical systems across VDI, DaaS, and cloud environments by reducing PHI exposure and supporting HIPAA-aligned security. 10ZiG helps healthcare leaders improve clinician experience while lowering TCO, risk, and operational complexity.